Ref. HZ-H7EQEB · businessbroker · Optométrie · Télésanté / Telehealth
Patented At-Home Vision Testing Platform
Asking Price: Not Disclosed
63% complete
« no financial data provided by the source · data quality 34/100 »
Description
A rare opportunity to acquire the only fully built, clinically validated, FDA-registered at-home vision diagnostics platform shipping at scale. A 29-patent portfolio pairs with proprietary, MIT-licensed optical technology and a HIPAA-compliant telehealth network that delivers prescriptions across 40 U.S. states. Over 50,000 devices sold in 150 countries over eight years of commercial operation - with zero product defects, zero MDRs, and zero product litigation throughout the entire history of the business.This is a continuation of the commercialization play, not a speculative technology-development bet.More than $31 million has been invested to date for software and product development, inventory, and marketplace testing.WHY THIS IS EXCEPTIONAL◉Patented, smartphone-based vision diagnostics platform - test vision, measure refractive error, and obtain prescriptions remotely.◉Exclusive license to MIT inverse Shack-Hartmann refraction technology — the foundational science behind the platfo
Where this listing comes from
We aggregate this listing from businessbroker; we do not publish or verify it. Price, figures and contact details are those provided by the source. Continue there to contact the seller.
View listing on businessbrokerSomething inaccurate, or the listing is gone? Tell us — we re-check it at the source.